...
首页> 外文期刊>Journal of biomedical science. >Dl-3-n-butylphthalide protects the heart against ischemic injury and H9c2 cardiomyoblasts against oxidative stress: involvement of mitochondrial function and biogenesis
【24h】

Dl-3-n-butylphthalide protects the heart against ischemic injury and H9c2 cardiomyoblasts against oxidative stress: involvement of mitochondrial function and biogenesis

机译:Dl-3-n-丁基邻苯二甲酸酯可保护心脏免受缺血性损伤,H9c2心肌成纤维细胞免受氧化应激:线粒体功能和生物发生

获取原文
   

获取外文期刊封面封底 >>

       

摘要

BackgroundMyocardial infarction (MI) is an acute and fatal condition that threatens human health. Dl-3-n-butylphthalide (NBP) has been used for the treatment of acute ischemic stroke. Mitochondria may play a protective role in MI injury. However, there are few reports on the cardioprotective effect of NBP or the potential mitochondrial mechanism for the NBP-induced protection against cardiac ischemia injury. We investigated the therapeutic effects of NBP in an in vivo MI model and an in vitro oxidative stress model, as well as the potential mitochondrial mechanism.MethodsThis study comprised two different experiments. The aim of experiment 1 was to determine the protective effects of NBP on MI and the underlying mechanisms in vivo. In part 1, myocardial infarct size was measured by staining with 2,3,5-triphenyltetrazoliumchloride (TTC). Myocardial enzymes and mitochondrial enzymes were assayed. The aim of experiment 2 was to investigate the role of NBP in H_(2)O_(2)-induced myocardial ischemic injury in H9c2 cells and to determine the potential mechanism. In part 2, H9c2 cell viability was evaluated. ROS levels, mitochondrial morphology, and mitochondrial membrane potential of H9c2 cells were measured. ATP levels were evaluated using an assay kit; mitochondrial DNA (mtDNA), the expressions of NRF-1 and TFAM, and mitochondrial biogenesis factors were determined.ResultsNBP treatment significantly reduced the infarct ratio, as observed by TTC staining, decreased serum myocardial enzymes in MI, and restored heart mitochondrial enzymes (isocitrate dehydrogenase (ICDH), succinate dehydrogenase (SDH), malate dehydrogenase (MDH), and a-ketoglutarate dehydrogenase (a-KGDH) activities after MI. Moreover, in in vitro studies, NBP significantly increased the viability of H9c2 cells in a dose-dependent manner, reduced cell apoptosis, protected mitochondrial functions, elevated the cellular ATP levels, and promoted H_(2)O_(2)-induced mitochondrial biogenesis in H9c2 cardiomyoblasts.ConclusionCollectively, the results from both the in vivo and in vitro experiments suggested that NBP exerted a cardioprotective effect on cardiac ischemic injury via the regulation of mitochondrial function and biogenesis.
机译:背景心肌梗塞(MI)是威胁人类健康的急性和致命疾病。 Dl-3-正丁基邻苯二甲酸酯(NBP)已用于治疗急性缺血性中风。线粒体可能在MI损伤中起保护作用。但是,关于NBP的心脏保护作用或NBP诱导的针对心肌缺血损伤的保护作用的潜在线粒体机制的报道很少。我们研究了NBP在体内MI模型和体外氧化应激模型中的治疗效果以及潜在的线粒体机制。方法本研究包括两个不同的实验。实验1的目的是确定NBP对MI的保护作用以及体内的潜在机制。在第1部分中,通过用2,3,5-三苯四唑氯化物(TTC)染色来测量心肌梗塞大小。测定了心肌酶和线粒体酶。实验2的目的是研究NBP在H9c2细胞中H_(2)O_(2)诱导的心肌缺血损伤中的作用,并确定其潜在机制。在第2部分中,评估了H9c2细胞的生存能力。测量H9c2细胞的ROS水平,线粒体形态和线粒体膜电位。使用测定试剂盒评估ATP水平;检测线粒体DNA(mtDNA),NRF-1和TFAM的表达以及线粒体生物发生因子。结果NBP治疗显着降低了梗死率,如TTC染色所观察到的,MI中的血清心肌酶减少,并且恢复了心脏线粒体酶(异柠檬酸) MI后脱氢酶(ICDH),琥珀酸脱氢酶(SDH),苹果酸脱氢酶(MDH)和α-酮戊二酸脱氢酶(a-KGDH)的活性。此外,在体外研究中,NBP在剂量-依赖的方式,减少细胞凋亡,保护线粒体功能,升高细胞ATP水平,并促进H9(2)O心肌细胞中H_(2)O_(2)诱导的线粒体生物发生。结论,体内和体外实验共同表明, NBP通过调节线粒体功能和生物发生,对心脏缺血性损伤发挥心脏保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号